Exhibit 99.1

NEWS
                                                     Delta and Pine Land Company
                                                     P.O. Box 157
                                                     Scott, Mississippi 38772
- --------------------------------------------------------------------------------
Contact:   Investors                               Media
           Tom Jagodinski                          Jonathan Gasthalter/Amy Cohen
           Delta and Pine Land Company             Citigate Sard Verbirinen
           (662) 742-4518                          (212) 687-8080


SUPREME COURT OF MISSISSIPPI GRANTS DELTA & PINE LAND PETITION TO APPEAL CERTAIN
MATTERS IN CASE AGAINST MONSANTO AND PHARMACIA

        D&PL Seeks to Amend Complaint to Add Fraudulent Inducement Claim

     SCOTT,  MS,  February  22, 2005 - Delta and Pine Land Company  (NYSE:  DLP)
("D&PL",  NYSE:  DLP), a leading  commercial  breeder,  producer and marketer of
cotton planting seed,  today announced that, in its litigation  against Monsanto
Company (NYSE:  MON) and Pharmacia,  the  Mississippi  Supreme Court has granted
D&PL's  petitions  to appeal two rulings  from the trial  court.  As a result of
these  rulings,   the  Mississippi   Supreme  Court  will  hear  D&PL's  appeals
immediately  instead of after trial.  The case relates to the failed 1998 merger
between the two companies.

     One  petition  related  to an appeal of an order  regarding  D&PL's  damage
claims.  In October 2004,  the Circuit Court of the First  Judicial  District of
Bolivar  County,  Mississippi  granted  Monsanto's  motion for  partial  summary
judgment  relating  to  one of  three  methods  of  calculating  D&PL's  damages
resulting from Monsanto's breach of the merger agreement.  That method sought to
calculate  the  "benefit of the bargain"  that D&PL would have  received had the
transaction  closed.  D&PL is  seeking  reversal  of that  order and a  decision
allowing  D&PL to present a jury with the  "benefit  of the  bargain"  method to
calculate damages.

     The second petition sought permission to appeal a discovery ruling relating
to documents  that Monsanto had claimed to be immune from  disclosure  under the
attorney-client  privilege and work product  doctrine.  The original trial judge
found that the documents were not  privileged and ordered  Monsanto to turn them
over to D&PL.  Monsanto turned over the documents to D&PL and allowed them to be
used by D&PL for eight  months  during  discovery.  After  those  eight  months,

                                       1


Monsanto filed a motion  seeking the return of the documents,  and the new trial
judge  ordered  D&PL to  return a  portion  of them.  D&PL is  seeking  a ruling
allowing it to retain the  documents  to use in the lawsuit on various  grounds,
including that they are not privileged and that - even if they were at one time
protected by a privilege - Monsanto turned them over and then allowed their use
in discovery for eight  months,  thus waiving any  privilege.  The Supreme Court
also issued a temporary stay of the Circuit Court  proceedings while the appeals
are resolved.

     Additionally,  D&PL has also filed a motion  with the trial  court to amend
its  complaint to add a claim against  Monsanto and  Pharmacia for  fraudulently
inducing  D&PL to extend the  deadline to complete  its Merger with  Monsanto in
1999.

     Tom Jagodinski,  President and Chief Executive Officer,  said, "We are very
pleased that the Supreme Court of Mississippi has agreed to hear our appeals. We
are confident in our legal position and hope to receive favorable decisions from
the Court. We are also hopeful that the Bolivar County,  Mississippi trial court
will allow us to amend our  complaint  based on  information  discovered  in the
lawsuit that supports our claim."

     About the Litigation against Monsanto and Pharmacia

     In 1998,  D&PL entered into a merger  agreement with what was then Monsanto
Company.   That  merger  was  pending  awaiting  regulatory  approval  from  the
Department of Justice for almost 19 months. In December 1999,  Monsanto withdrew
its request for antitrust clearance,  thereby terminating the merger, and at the
same time  entered into a merger  agreement  with  Pharmacia & Upjohn.  D&PL has
filed suit in Bolivar County, Mississippi against Monsanto claiming, among other
things,  that Monsanto  breached the merger agreement with D&PL by not using its
best efforts to close the merger and failing to make the necessary  commercially
reasonable  efforts to meet the  government's  requirements to obtain  antitrust
clearance for the merger.

     About Delta and Pine Land Company

     Delta and Pine Land Company is a leading commercial  breeder,  producer and
marketer of cotton  planting seed.  Headquartered  in Scott,  Mississippi,  with
multiple  offices in eight states and facilities in several  foreign  countries,
D&PL also breeds,  produces and markets  soybean  planting  seed in the U.S. For
more  information   about  D&PL,  please  refer  to  the  Company's  website  at
www.deltaandpine.com.


                                        2


     Certain matters discussed in this release are "forward-looking statements,"
including  statements about the Company's  future plans,  goals and other events
which have not yet occurred.  These  statements  are intended to qualify for the
safe harbors from liability provided by the Private Securities Litigation Reform
Act of 1995.  They can  generally  be  identified  because  the  context of such
statements  will include words such as "believes,"  "anticipates,"  "expects" or
words of similar import.  It is the nature of agricultural  seed businesses that
supply,  demand  and their  timing are  affected  by many  variables,  including
commodity prices,  weather and government  policy. Due to the seasonal nature of
the seed business,  the Company  typically incurs losses in its first and fourth
quarters.  Additional  risks and  uncertainties  with  respect to the  Company's
business and  forward-looking  statements are set forth in the Company's  latest
filings with the Securities and Exchange Commission.


                                      ###



















                                        3